GO:0180046 GPI anchored protein biosynthesis: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0180046 describes the post-translational modification of proteins with a glycosylphosphatidylinositol (GPI) anchor, enabling them to attach to the cell membrane and achieve full functional capacity.
• The process occurs in the endoplasmic reticulum (ER) and involves a multi-step pathway with over 20 genes, including PIGA, PIGB, PIGC, and others.
• Defects in GPI anchor biosynthesis cause paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening blood disorder.
• GPI-anchored proteins are critical for immune recognition, signal transduction, and cell adhesion, and are implicated in malaria pathogenesis.
• Research tools such as CRISPR knockout, point mutation, and knock-in models are essential to dissect gene function in this pathway.
• Understanding GPI anchor biosynthesis offers therapeutic targets for PNH, cancer, and infectious diseases.
Description
GPI anchored protein biosynthesis (GO:0180046) is a vital biological process that attaches a glycosylphosphatidylinositol (GPI) anchor to proteins, allowing them to be tethered to the cell membrane. This post-translational modification is essential for the function of numerous cell surface proteins involved in immune response, signal transduction, and cell adhesion. The pathway is highly conserved across eukaryotes and occurs primarily in the endoplasmic reticulum (ER), where a complex enzymatic machinery assembles the GPI anchor and transfers it to target proteins. Researchers study this process to understand its role in health and disease, as defects in GPI anchor biosynthesis lead to severe disorders such as paroxysmal nocturnal hemoglobinuria (PNH). Moreover, GPI-anchored proteins are critical for the virulence of certain pathogens, including the malaria parasite. The clinical and biological significance of this pathway makes it a prime target for therapeutic intervention and a focus of intense research.
GPI anchored protein biosynthesis At A Glance
| GO ID | GO:0180046 |
|---|---|
| GO term | GPI anchored protein biosynthesis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Post-translational modification of proteins with a GPI anchor |
| Cellular location | Endoplasmic reticulum (ER) |
| Key enzymes | PIGA, PIGB, PIGC, PIGF, PIGG, PIGH, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGX, PIGY, PIGZ |
| Associated diseases | Paroxysmal nocturnal hemoglobinuria (PNH) |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, flow cytometry, mass spectrometry |
What Is GO:0180046?
According to the Gene Ontology, GO:0180046 (GPI anchored protein biosynthesis) is defined as any process leading to the post-translational modification of a protein with a GPI anchor to achieve full functional capacity of the protein. In simpler terms, it is the cellular process that attaches a GPI anchor to proteins, enabling them to be anchored to the cell membrane and perform their functions.
Why Is GPI anchored protein biosynthesis Important in Cell Biology?
GPI anchored protein biosynthesis is crucial because it governs the surface expression of many proteins that mediate essential cellular processes, including immune recognition, signal transduction, and cell adhesion. Disruption of this pathway leads to diseases such as PNH, a clonal hematopoietic stem cell disorder characterized by complement-mediated hemolysis. Additionally, GPI-anchored proteins are key virulence factors in pathogens like Plasmodium falciparum, the causative agent of malaria. Understanding the molecular details of GPI anchor biosynthesis can inform the development of novel therapeutics for these conditions.
• Enables membrane attachment of over 150 human proteins, including receptors, enzymes, and adhesion molecules.
• Defects in GPI biosynthesis cause PNH, a disease with significant morbidity and mortality.
• GPI-anchored proteins are involved in immune surveillance and complement regulation.
• The pathway is essential for the virulence of malaria parasites.
• GPI anchor biosynthesis is a potential target for anti-parasitic and anti-cancer therapies.
• Research on this pathway provides insights into protein sorting and ER biology.
• Mutations in GPI pathway genes are associated with developmental disorders.
• GPI-anchored proteins serve as biomarkers for certain cancers and stem cells.
• The pathway is conserved from yeast to humans, facilitating model organism studies.
• CRISPR-based editing of GPI pathway genes enables functional dissection and drug discovery.
What Happens During GPI anchored protein biosynthesis?
Step 1: Synthesis of the GPI anchor precursor
In simple terms: The cell builds the GPI anchor piece by piece in the ER membrane.
The biosynthesis of the GPI anchor begins on the cytoplasmic side of the endoplasmic reticulum (ER) membrane with the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI), catalyzed by the PIGA/PIGC/PIGH complex. Subsequent steps add three mannose residues and an ethanolamine phosphate (EtNP) to form the complete GPI anchor precursor, which then flips to the luminal side of the ER. This precursor is then ready to be attached to proteins.
Step 2: Attachment of the GPI anchor to proteins
In simple terms: The pre-assembled GPI anchor is attached to the C-terminus of a target protein.
Proteins destined for GPI anchoring have a C-terminal GPI attachment signal peptide. The transamidase complex, composed of PIGK, PIGS, PIGT, PIGU, and GPAA1, cleaves this signal peptide and replaces it with the GPI anchor via an amide bond. This reaction occurs in the ER lumen and is essential for the stable association of the protein with the membrane.
Step 3: Remodeling and transport of GPI-anchored proteins
In simple terms: The GPI anchor is fine-tuned and the protein is sent to the cell surface.
After attachment, the GPI anchor undergoes remodeling, including the removal of an inositol-linked acyl chain and the addition of a palmitate, which is necessary for association with lipid rafts. The GPI-anchored proteins are then transported from the ER to the Golgi and eventually to the plasma membrane, where they perform their functions. This trafficking is mediated by specific cargo receptors and is regulated by the lipid environment.
Step 4: Quality control and degradation
In simple terms: Misfolded or unassembled GPI-anchored proteins are checked and destroyed if faulty.
The ER quality control system ensures that only properly folded and GPI-anchored proteins proceed to the Golgi. Misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome. Additionally, accumulated precursors of specific GPI-anchored proteins can upregulate GPI biosynthesis through a feedback mechanism involving ARV1. This regulation maintains homeostasis of GPI-anchored proteins at the cell surface.
Key Genes Involved in GO:0180046 GPI anchored protein biosynthesis
The following genes encode enzymes and subunits involved in GPI anchored protein biosynthesis, many of which are conserved from yeast to humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGA | Catalyzes the first step of GPI anchor biosynthesis | Mutations cause PNH; target for knockout studies |
| PIGB | Mannosyltransferase in GPI anchor assembly | Essential for GPI biosynthesis; knockout lethal in mice |
| PIGC | Component of the GPI-N-acetylglucosaminyltransferase complex | Required for early GPI biosynthesis |
| PIGF | Ethanolamine phosphate transferase | Mutations linked to developmental disorders |
| PIGG | Ethanolamine phosphate transferase | Involved in GPI anchor maturation |
| PIGH | Component of the GPI-N-acetylglucosaminyltransferase complex | Essential for GPI biosynthesis |
| PIGK | Catalytic subunit of GPI transamidase | Required for GPI attachment to proteins |
| PIGL | De-N-acetylase in GPI biosynthesis | Mutations cause CHIME syndrome |
| PIGM | Mannosyltransferase | Defects cause GPI deficiency and epilepsy |
| PIGN | Mannosyltransferase | Mutations cause multiple congenital anomalies |
| PIGO | Ethanolamine phosphate transferase | Mutations cause Mabry syndrome |
| PIGP | Component of GPI transamidase | Required for GPI attachment |
| PIGQ | Component of GPI-N-acetylglucosaminyltransferase complex | Essential for GPI biosynthesis |
| PIGS | Component of GPI transamidase | Required for GPI attachment |
| PIGT | Component of GPI transamidase | Mutations cause developmental delay |
| PIGU | Component of GPI transamidase | Required for GPI attachment |
| PIGV | Mannosyltransferase | Mutations cause Mabry syndrome |
| PIGW | Acyltransferase in GPI biosynthesis | Required for GPI anchor remodeling |
| PIGX | Mannosyltransferase | Involved in GPI anchor assembly |
| PIGY | Component of GPI transamidase | Required for GPI attachment |
| PIGZ | Mannosyltransferase | Involved in GPI anchor assembly |
How Is GPI anchored protein biosynthesis Regulated?
GPI anchored protein biosynthesis is regulated at multiple levels. The pathway is subject to feedback regulation by the accumulation of GPI-anchored protein precursors, which can upregulate GPI biosynthesis genes through ARV1. Additionally, the expression of GPI pathway genes is influenced by cellular stress and metabolic status. Post-translational modifications of GPI enzymes, such as phosphorylation, may also modulate their activity. However, the precise regulatory mechanisms remain an active area of research.
GPI anchored protein biosynthesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGA | Paroxysmal nocturnal hemoglobinuria (PNH) | Knockout in hematopoietic stem cells |
| PIGN | Multiple congenital anomalies-hypotonia-seizures syndrome | Knockout mouse |
| PIGO | Mabry syndrome | Patient-derived iPSCs |
| PIGT | Developmental delay and epilepsy | Knock-in mouse |
| PIGV | Mabry syndrome | Zebrafish knockout |
Paroxysmal Nocturnal Hemoglobinuria (PNH)
PNH is an acquired hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, leading to a deficiency in GPI-anchored proteins on the surface of blood cells. This deficiency renders red blood cells susceptible to complement-mediated lysis, causing hemolysis, thrombosis, and bone marrow failure. The absence of GPI-anchored complement inhibitors such as CD55 and CD59 is central to the pathophysiology of PNH.
Developmental Disorders
Mutations in various GPI biosynthesis genes, including PIGN, PIGO, PIGV, and PIGT, are associated with a spectrum of developmental disorders characterized by intellectual disability, seizures, and multiple congenital anomalies. These disorders, such as Mabry syndrome and CHIME syndrome, highlight the critical role of GPI-anchored proteins in embryonic development.
Infectious Diseases
GPI-anchored proteins are essential for the virulence of several pathogens. In Plasmodium falciparum, the major surface protein of sporozoites is GPI-anchored to the plasma membrane, facilitating host cell invasion. Targeting GPI biosynthesis in parasites is a potential therapeutic strategy.
From GPI anchored protein biosynthesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of PIGA in GPI anchor biosynthesis? | PIGA knockout cell line |
| How do point mutations in PIGV affect enzyme activity? | PIGV point mutation knock-in |
| Can we rescue GPI anchor deficiency with synthetic GPI? | GPI-deficient cells treated with synthetic GPI oligosaccharides |
| What is the effect of PIGT overexpression on GPI-anchored protein levels? | PIGT overexpression cell line |
| How does ARV1 regulate GPI biosynthesis? | ARV1 knockout and overexpression |
| What is the role of GPI-anchored proteins in malaria invasion? | Plasmodium sporozoite GPI-anchored protein knockout |
How to Study the GPI anchored protein biosynthesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface expression of GPI-anchored proteins | Diagnosis of PNH |
| Mass spectrometry | Identification and quantification of GPI-anchored proteins | Proteomic profiling |
| CRISPR-Cas9 knockout | Gene function | Studying PIGA in PNH |
| CRISPR point mutation | Effect of specific mutations | Modeling PIGV mutations |
| CRISPR knock-in | Tagged protein expression | Localization studies |
| Overexpression | Gain-of-function effects | Rescue experiments |
| Metabolic labeling | GPI biosynthesis intermediates | Pathway kinetics |
| RNA-seq | Transcriptional changes | Regulation of GPI genes |
Flow Cytometry
Flow cytometry is widely used to detect GPI-anchored proteins on the cell surface using fluorescently labeled antibodies or GPI-specific probes such as aerolysin. This method allows quantification of GPI-anchored protein expression and assessment of GPI anchor deficiency in patient samples, such as in PNH.
Mass Spectrometry
Mass spectrometry-based proteomics can identify and quantify GPI-anchored proteins and their post-translational modifications. It is used to study the composition of the GPI anchor and to detect abnormalities in GPI biosynthesis.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 knockout, point mutation, and knock-in models are powerful tools to dissect the function of GPI biosynthesis genes. These models enable precise genetic manipulation to study the effects on GPI anchor biosynthesis and downstream phenotypes.
Metabolic Labeling
Metabolic labeling with radioactive precursors (e.g., [3H]mannose) or click chemistry probes allows tracking of GPI anchor biosynthesis intermediates. This method is useful for studying the kinetics and regulation of the pathway.
How CRISPR Can Be Used to Study GO:0180046 GPI anchored protein biosynthesis
Knockout
CRISPR knockout of GPI biosynthesis genes, such as PIGA, results in the loss of GPI-anchored proteins from the cell surface, mimicking PNH. These models are used to study the consequences of GPI anchor deficiency and to test therapeutic strategies.
Point Mutation
Introducing point mutations in GPI pathway genes, such as PIGV, allows researchers to model human developmental disorders and assess the impact on enzyme activity and GPI anchor biosynthesis. These models are valuable for understanding genotype-phenotype correlations.
Knock-in
Knock-in of tagged GPI biosynthesis genes (e.g., GFP-PIGK) enables real-time visualization of protein localization and dynamics in live cells. This approach helps to dissect the spatiotemporal regulation of GPI anchor biosynthesis.
Overexpression
Overexpression of GPI biosynthesis genes, such as PIGT, can rescue GPI anchor deficiency in mutant cells and is used to study the effects of increased GPI-anchored protein levels on cell signaling and adhesion.
How EDITGENE Supports GPI anchored protein biosynthesis Research
Researchers studying GPI anchored protein biosynthesis-related genes often need to determine whether a candidate gene is causally involved in the pathway or in associated diseases. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for GPI anchored protein biosynthesis research.
Frequently Asked Questions About GPI anchored protein biosynthesis
What is GPI anchored protein biosynthesis?
GPI anchored protein biosynthesis (GO:0180046) is the process of attaching a glycosylphosphatidylinositol (GPI) anchor to proteins, enabling them to attach to the cell membrane and function properly.
What genes are involved in GPI anchored protein biosynthesis?
Over 20 genes are involved, including PIGA, PIGB, PIGC, PIGF, PIGG, PIGH, PIGK, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGS, PIGT, PIGU, PIGV, PIGW, PIGX, PIGY, and PIGZ.
What diseases are associated with defects in GPI anchored protein biosynthesis?
Defects cause paroxysmal nocturnal hemoglobinuria (PNH) and various developmental disorders such as Mabry syndrome and CHIME syndrome.
How is GPI anchored protein biosynthesis studied?
Common methods include flow cytometry, mass spectrometry, CRISPR-Cas9 genome editing, and metabolic labeling.
What is the role of PIGA in GPI anchored protein biosynthesis?
PIGA catalyzes the first step of GPI anchor biosynthesis, and its mutation leads to PNH.
Can CRISPR be used to study GPI anchored protein biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this pathway.
What is the cellular location of GPI anchored protein biosynthesis?
The pathway occurs primarily in the endoplasmic reticulum (ER).
How does GPI anchor biosynthesis regulate protein function?
The GPI anchor tethers proteins to the membrane, allowing them to participate in cell signaling, adhesion, and immune recognition.
What are GPI-anchored proteins?
GPI-anchored proteins are proteins attached to the cell membrane via a glycosylphosphatidylinositol anchor, including receptors, enzymes, and adhesion molecules.
Why is GPI anchored protein biosynthesis important for malaria?
The major surface protein of malaria sporozoites is GPI-anchored, which is essential for host cell invasion.
Conclusion
GPI anchored protein biosynthesis (GO:0180046) is a fundamental cellular process that modifies proteins with a GPI anchor, enabling their attachment to the cell membrane and proper function. This pathway is critical for immune response, signal transduction, and development, and its disruption leads to diseases such as PNH and congenital disorders. Ongoing research using CRISPR-based models and advanced proteomics continues to unravel the molecular details of GPI anchor biosynthesis, offering new avenues for therapeutic intervention. EDITGENE's comprehensive services support these efforts by providing custom cell models and screening platforms.
References
- 1. Kinoshita T. 2020. Biosynthesis and biology of mammalian GPI-anchored proteins.. Open Biol 10(3):190290 PMID: 32156170
- 2. Brodsky RA. 2014. Paroxysmal nocturnal hemoglobinuria.. Blood 124(18):2804-11 PMID: 25237200
- 3. Kinoshita T. 2024. Towards a thorough understanding of mammalian glycosylphosphatidylinositol-anchored protein biosynthesis.. Glycobiology 34(11) PMID: 39129667
- 4. Guerrero PA et al.. 2021. Rescue of Glycosylphosphatidylinositol-Anchored Protein Biosynthesis Using Synthetic Glycosylphosphatidylinositol Oligosaccharides.. ACS Chem Biol 16(11):2297-2306 PMID: 34618440
- 5. Ikezawa H. 2002. Glycosylphosphatidylinositol (GPI)-anchored proteins.. Biol Pharm Bull 25(4):409-17 PMID: 11995915
- 6. Liu YS et al.. 2023. Accumulated precursors of specific GPI-anchored proteins upregulate GPI biosynthesis with ARV1.. J Cell Biol 222(5) PMID: 36828365
- 7. Yuan Y et al.. 2024. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication.. Signal Transduct Target Ther 9(1):60 PMID: 38485938
- 8. Nagar R et al.. 2024. The major surface protein of malaria sporozoites is GPI-anchored to the plasma membrane.. J Biol Chem 300(8):107557 PMID: 39002668
